Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates

Journal of General Virology

Volumn 95, Issue PART 5, 2014, Pages 1083-1093

  Li, Jingliang ^a   Chang, Junliang ^a   Liu, Xin ^a   Yang, Jiaxin ^a   Guo, Haoran ^a,b   Wei, Wei ^a,b   Zhang, Wenyan ^a   Yu, Xiao Fang ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT COXSACKIEVIRUS A16 VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COXSACKIE VIRUS A; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS A16; CYTOPATHOGENIC EFFECT; FEMALE; HUMAN; HUMORAL IMMUNITY; IN VITRO STUDY; LETHAL DOSE; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; ENTEROVIRUS; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL LOAD; VIRAL VACCINES;

EID: 84899679713     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.063560-0     Document Type: Article

References (28)

1. Ang, L. W., Koh, B. K., Chan, K. P., Chua, L. T., James, L. & Goh, K. T. (2009). Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 38, 106-112.
2. Bendig, J. W. & Fleming, D. M. (1996). Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun Dis Rep CDR Rev 6, R81-R86.
3. Chan, Y. F. & AbuBakar, S. (2005). Human enterovirus 71 subgenotype B3 lacks coxsackievirus A16-like neurovirulence in mice infection. Virol J 2, 74.
4. Chen, S. C., Chang, H. L., Yan, T. R., Cheng, Y. T. & Chen, K. T. (2007). An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 77, 188-191.
5. Chen, C. W., Lee, Y. P., Wang, Y. F. & Yu, C. K. (2011). Formaldehydeinactivated human enterovirus 71 vaccine is compatible for coimmunization with a commercial pentavalent vaccine. Vaccine 29, 2772-2776.
6. Hagiwara, A., Tagaya, I. & Yoneyama, T. (1978). Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9, 60-63.
7. Ho, M., Chen, E. R., Hsu, K. H., Twu, S. J., Chen, K. T., Tsai, S. F., Wang, J. R., Shih, S. R. & Taiwan Enterovirus Epidemic Working Group (1999). An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341, 929-935.
8. Kao, S. J., Yang, F. L., Hsu, Y. H. & Chen, H. I. (2004). Mechanism of fulminant pulmonary edema caused by enterovirus 71. Clin Infect Dis 38, 1784-1788.
9. Legay, F., Lévêque, N., Gacouin, A., Tattevin, P., Bouet, J., Thomas, R. & Chomel, J. J. (2007). Fatal coxsackievirus A-16 pneumonitis in adult. Emerg Infect Dis 13, 1084-1086.
10. Li, Y., Zhu, R., Qian, Y., Deng, J., Sun, Y., Liu, L., Wang, F. & Zhao, L. (2011). Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s. BMC Microbiol 11, 246.
11. Liu, Q., Yan, K., Feng, Y., Huang, X., Ku, Z., Cai, Y., Liu, F., Shi, J. & Huang, Z. (2012). A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 30, 6642-6648.
12. Ma, E., Fung, C., Yip, S. H., Wong, C., Chuang, S. K. & Tsang, T. (2011). Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks. Pediatr Infect Dis J 30, 675-679.
13. Mao, Q., Wang, Y., Gao, R., Shao, J., Yao, X., Lang, S., Wang, C., Mao, P., Liang, Z. & Wang, J. (2012). A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol 86, 11967-11976.
14. Meng, F. Y., Li, J. X., Li, X. L., Chu, K., Zhang, Y. T., Ji, H., Li, L., Liang, Z. L. & Zhu, F. C. (2012). Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother 8, 668-674.
15. Nishimura, Y., Shimojima, M., Tano, Y., Miyamura, T., Wakita, T. & Shimizu, H. (2009). Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15, 794-797.
16. Qiu, J. (2008). Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7, 868-869.
17. Sarkis, P. T., Ying, S., Xu, R. & Yu, X. F. (2006). STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J Immunol 177, 4530-4540.
18. Vijayaraghavan, P. M., Chandy, S., Selvaraj, K., Pulimood, S. & Abraham, A. M. (2012). Virological investigation of hand, foot, and mouth disease in a tertiary care center in South India. J Glob Infect Dis 4, 153-161.
19. Wang, C. Y., Li Lu, F., Wu, M. H., Lee, C. Y. & Huang, L. M. (2004). Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23, 275-276.
20. Wright, H. T., Jr, Landing, B. H., Lennette, E. H. & McAllister, R. M. (1963). Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med 268, 1041-1044.
21. Wu, C. N., Lin, Y. C., Fann, C., Liao, N. S., Shih, S. R. & Ho, M. S. (2001). Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20, 895-904.
22. Wu, T. C., Wang, Y. F., Lee, Y. P., Wang, J. R., Liu, C. C., Wang, S. M., Lei, H. Y., Su, I. J. & Yu, C. K. (2007). Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol 81, 10310-10315.
23. Wu, P. C., Huang, L. M., Kao, C. L., Fan, T. Y., Cheng, A. L. & Chang, L. Y. (2010). An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei. J Microbiol Immunol Infect 43, 271-277.
24. Yamayoshi, S., Yamashita, Y., Li, J., Hanagata, N., Minowa, T., Takemura, T. & Koike, S. (2009). Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15, 798-801.
25. Yan, X. F., Gao, S., Xia, J. F., Ye, R., Yu, H. & Long, J. E. (2012). Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis 44, 297-305.
26. Yang, F., Zhang, T., Hu, Y., Wang, X., Du, J., Li, Y., Sun, S., Sun, X., Li, Z. & Jin, Q. (2011). Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 8, 508.
27. Yen, F. B., Chang, L. Y., Kao, C. L., Lee, P. I., Chen, C. M., Lee, C. Y., Shao, P. L., Wang, S. C., Lu, C. Y. & Huang, L. M. (2009). Coxsackieviruses infection in northern Taiwan-epidemiology and clinical characteristics. J Microbiol Immunol Infect 42, 38-46.
28. Zhao, K., Han, X., Wang, G., Hu, W., Zhang, W. & Yu, X. F. (2011). Circulating coxsackievirus A16 identified as recombinant type A human enterovirus, China. Emerg Infect Dis 17, 1537-1540.